Epilepsy Clinical Trial
— COMETEOfficial title:
COMET Study Effectiveness of a Cognitive Remediation Program of Memory in Patients With Temporal Lobe Epilepsy
Studies on the cognitive function have highlighted promising results concerning attention. In
contrast, in the field of memory, the single cohort study that has been carried out, has not
been randomised, with non comparable groups, the significant outcomes are therefore to be
balanced.
In this study, patients with focal and structural temporal lobe epilepsy will be randomised
in 2 groups : the COMETE group where patients will attend a specific rehabilitation programme
of memory and the control group where patients will benefit from a standard treatment.
Status | Recruiting |
Enrollment | 120 |
Est. completion date | January 3, 2021 |
Est. primary completion date | September 3, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Adults with structural temporal lobe epilepsy, according to Fischer et al (2005) criteria. - Patients aged 18-70 - Patients with epilepsy for more than 2 year - Patients with mild to severe memory impairment (minimum score : -1,6s / average at Buschke Reminding Test, learning index - Patients with equal or higher Intellectual Quotient than 70 (WAIS-IV) - stabilized anti epileptic treatment (same treatment for the last 6 months) - Patient who has given informed consent in writing - Patients with social insurance - Patients with internet connexion for weekly training at home Exclusion Criteria: - other progressive associated neurological (history of stroke for example) or psychiatric disease - temporal lobe surgery within following 12 months - presence of a progressive brain lesion - legally protected adults or adults incapable of giving informed consent - persons who are deprived of their liberty by judicial or administrative decision |
Country | Name | City | State |
---|---|---|---|
France | Service de Neurologie, Hôpital Central, CHRU de Nancy | Nancy | Lorraine |
Lead Sponsor | Collaborator |
---|---|
Central Hospital, Nancy, France | Centre Hospitalier Universitaire Dijon, CHU de Reims, University Hospital, Strasbourg, France |
France,
Brissart H, Daniel F, Morele E, Leroy M, Debouverie M, Defer GL. [Cognitive rehabilitation in multiple sclerosis: a review of the literature]. Rev Neurol (Paris). 2011 Apr;167(4):280-90. doi: 10.1016/j.neurol.2010.07.039. Epub 2010 Dec 21. Review. French. — View Citation
Brissart H, Leroy M, Morele E, Baumann C, Spitz E, Debouverie M. Cognitive rehabilitation in multiple sclerosis. Neurocase. 2013;19(6):553-65. doi: 10.1080/13554794.2012.701644. Epub 2012 Aug 1. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Buschke Reminding Test, learning index | this is a task of verbal memory : neuropsychologist read a list of 15 words, and patient must repeat a maximum of them | 20 minutes | |
Secondary | digit span | this is a task of immediate memory : neuropsychologist read digit, and subject must recall them in the same order | 5 minutes | |
Secondary | Visual memory task | this is a task of visual memory : subject must memorize a grid | 10 minutes | |
Secondary | verbal fluencies | The performance measure is the total number of words that patient give in two minutes. there is two conditions : phonological condition : patient must recall words that start with the letter P; semantic condition : patient must recall words from animal category | 5 minutes | |
Secondary | Attentional tasks (TEA Battery) | This is attentional task on computer | 10 minutes | |
Secondary | Beck Depression Inventory | this is an inventory of depression | 10 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04595513 -
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
|
Phase 1/Phase 2 | |
Completed |
NCT02909387 -
Adapting Project UPLIFT for Blacks in Georgia
|
N/A | |
Completed |
NCT05552924 -
Self Acupressure on Fatigue and Sleep Quality in Epilepsy Patients
|
N/A | |
Terminated |
NCT01668654 -
Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS
|
Phase 3 | |
Not yet recruiting |
NCT05068323 -
Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients
|
N/A | |
Completed |
NCT03994718 -
Creative Arts II Study
|
N/A | |
Recruiting |
NCT04076449 -
Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
|
||
Completed |
NCT00782249 -
Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy
|
N/A | |
Completed |
NCT03683381 -
App-based Intervention for Treating Insomnia Among Patients With Epilepsy
|
N/A | |
Recruiting |
NCT05101161 -
Neurofeedback Using Implanted Deep Brain Stimulation Electrodes
|
N/A | |
Active, not recruiting |
NCT06034353 -
Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients
|
N/A | |
Recruiting |
NCT05769933 -
Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
|
||
Not yet recruiting |
NCT06408428 -
Glioma Intraoperative MicroElectroCorticoGraphy
|
N/A | |
Not yet recruiting |
NCT05559060 -
Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction)
|
||
Completed |
NCT02646631 -
Behavioral and Educational Tools to Improve Epilepsy Care
|
N/A | |
Completed |
NCT02977208 -
Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use
|
Phase 4 | |
Completed |
NCT02952456 -
Phenomenological Approach of Epilepsy in Patients With Epilepsy
|
||
Recruiting |
NCT02539134 -
TAK-935 Multiple Rising Dose Study in Healthy Participants
|
Phase 1 | |
Terminated |
NCT02757547 -
Transcranial Magnetic Stimulation for Epilepsy
|
N/A | |
Completed |
NCT02491073 -
Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)
|
N/A |